CLOSTRIDIUM DIFFICILE INFECTIONS
Clinical trials for CLOSTRIDIUM DIFFICILE INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIUM DIFFICILE INFECTIONS trials appear
Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cocktail of good bacteria break the cycle of c. diff?
Disease control Recruiting nowThis large Phase 3 trial tests whether VE303, a capsule containing 8 harmless bacteria, can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had at least one prior C. diff infection will take VE303 or a placebo for 14 days. The main goal is …
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTIONS
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
C. diff mystery: new study aims to unlock why infections keep coming back
Knowledge-focused Recruiting nowThis study follows 100 hospitalized patients with Clostridioides difficile infection to track how quickly the bacteria clears from the gut during and after standard antibiotic treatment. Researchers will also analyze gut bacteria and immune responses in stool samples to identify …
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTIONS
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC